Literature DB >> 644616

Experimental cerebral infarction. Part 1: Production of thalamic infarction in dogs.

T Yoshimoto, T Sakamoto, J Suzuki.   

Abstract

Difficulties in achieving focal temporary cerebral ischemia in experimental animals have delayed study of the prevention and treatment of cerebral infarction. We have succeeded in producing focal cerebral infarction by temporary occlusion of brain arteries. Infarction confined to the anterior portion of the thalamus was obtained by simultaneous occlusion of the 4 cerebral arteries: internal carotid, anterior cerebral, middle cerebral and posterior communicating arteries for 60-120 minutes. This experimental model in dogs is unique, since thalamic infarction can be produced with high frequency, and the dogs can be kept alive and managed for sufficient periods after temporary artery clipping. With this model it is possible to investigate cerebral infarction not only from the pathophysiological viewpoint, but also from the viewpoint of prevention and treatment of cerebral infarction in man.

Entities:  

Mesh:

Year:  1978        PMID: 644616     DOI: 10.1161/01.str.9.3.211

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Recirculation in the acute period of cerebral infarction: experimental research on brain swelling and its suppression by using mannitol or glycerol.

Authors:  J Suzuki; S Tanaka; T Yoshimoto; H Seki
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

2.  Experimental study of new cerebral protective substances - functional recovery of severe, incomplete ischaemic brain lesions pretreated with mannitol an fluorocarbon emulsion.

Authors:  K Mizoi; T Yoshimoto; J Suzuki
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

3.  Canine model of ischemic stroke with permanent middle cerebral artery occlusion: clinical and histopathological findings.

Authors:  Byeong-Teck Kang; Jong-Hwan Lee; Dong-In Jung; Chul Park; Su-Hyun Gu; Hyo-Won Jeon; Dong-Pyo Jang; Chae-Young Lim; Fu-Shi Quan; Young-Bo Kim; Zang-Hee Cho; Eung-Je Woo; Hee-Myung Park
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.